Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.

Chew EY, Klein ML, Clemons TE, Agrón E, Ratnapriya R, Edwards AO, Fritsche LG, Swaroop A, Abecasis GR; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2014 Nov;121(11):2173-80. doi: 10.1016/j.ophtha.2014.05.008. Epub 2014 Jun 26.

2.

The effect of health education video on ocular massage after trabeculectomy.

Hua L, Yingjuan L, Jingshu Z, Wei C.

Comput Inform Nurs. 2014 Jun;32(6):294-8. doi: 10.1097/CIN.0000000000000062.

PMID:
24937652
3.

Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.

Akuffo KO, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J.

Ophthalmic Epidemiol. 2014 Apr;21(2):111-23. doi: 10.3109/09286586.2014.888085.

4.

Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.

Age-Related Eye Disease Study 2 Research Group, Huynh N, Nicholson BP, Agrón E, Clemons TE, Bressler SB, Rosenfeld PJ, Chew EY.

Ophthalmology. 2014 Jun;121(6):1229-36. doi: 10.1016/j.ophtha.2013.12.035. Epub 2014 Mar 7.

5.

Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

JAMA Ophthalmol. 2014 Mar;132(3):272-7. doi: 10.1001/jamaophthalmol.2013.6636.

PMID:
24385141
6.

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.

JAMA Ophthalmol. 2014 Feb;132(2):142-9. doi: 10.1001/jamaophthalmol.2013.7376.

7.

Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians.

Christen WG, Glynn RJ, Manson JE, MacFadyen J, Bubes V, Schvartz M, Buring JE, Sesso HD, Gaziano JM.

Ophthalmology. 2014 Feb;121(2):525-34. doi: 10.1016/j.ophtha.2013.09.038. Epub 2013 Nov 20.

8.

Effects of patient education and therapeutic suggestions on cataract surgery patients: a randomized controlled clinical trial.

Kekecs Z, Jakubovits E, Varga K, Gombos K.

Patient Educ Couns. 2014 Jan;94(1):116-22. doi: 10.1016/j.pec.2013.09.019. Epub 2013 Oct 12.

9.

CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.

Awh CC, Lane AM, Hawken S, Zanke B, Kim IK.

Ophthalmology. 2013 Nov;120(11):2317-23. doi: 10.1016/j.ophtha.2013.07.039. Epub 2013 Aug 21.

PMID:
23972322
10.

Vitamins for age-related macular degeneration demonstrate minimal differences.

Kolber MR, Tennant M, Nickonchuk T.

Can Fam Physician. 2013 May;59(5):503. No abstract available.

11.

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Age-Related Eye Disease Study 2 Research Group.

JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997. Erratum in: JAMA. 2013 Jul 10;310(2):208.

PMID:
23644932
12.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10. Erratum in: Ophthalmology. 2016 Dec;123(12 ):2634.

13.

Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33.

Koo E, Chang JR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Research Group.

Ophthalmic Epidemiol. 2013 Apr;20(2):71-81. doi: 10.3109/09286586.2012.759598.

PMID:
23510310
14.

MP-1 biofeedback: luminous pattern stimulus versus acoustic biofeedback in age related macular degeneration (AMD).

Vingolo EM, Salvatore S, Limoli PG.

Appl Psychophysiol Biofeedback. 2013 Mar;38(1):11-6. doi: 10.1007/s10484-012-9203-4.

PMID:
22903517
15.

Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians.

Christen WG, Glynn RJ, Sesso HD, Kurth T, Macfadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM.

Ophthalmology. 2012 Aug;119(8):1642-9. doi: 10.1016/j.ophtha.2012.01.053. Epub 2012 Apr 13.

16.

Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.

Piermarocchi S, Saviano S, Parisi V, Tedeschi M, Panozzo G, Scarpa G, Boschi G, Lo Giudice G; Carmis Study Group.

Eur J Ophthalmol. 2012 Mar-Apr;22(2):216-25. doi: 10.5301/ejo.5000069.

PMID:
22009916
17.

Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.

Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ.

Korean J Ophthalmol. 2011 Oct;25(5):323-8. doi: 10.3341/kjo.2011.25.5.323. Epub 2011 Sep 20.

18.

The effects of Mozart's music on the performance of glaucoma patients on automated perimetry.

Shue B, Chatterjee A, Fudemberg S, Katz LJ, Moster MR, Navarro MJ, Pro M, Schmidt C, Spaeth GL, Stirbu O, Yalcin A, Myers JS.

Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7347-9. doi: 10.1167/iovs.11-7430.

PMID:
21828156
19.

Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.

Chang JR, Koo E, Agrón E, Hallak J, Clemons T, Azar D, Sperduto RD, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study Group.

Ophthalmology. 2011 Nov;118(11):2113-9. doi: 10.1016/j.ophtha.2011.03.032.

20.

A post-trial survey to assess the impact of dissemination of results and unmasking on participants in a 13-year randomised controlled trial on age-related cataract.

Williams SL, Ferrigno L, Maraini G, Rosmini F, Sperduto RD.

Trials. 2011 Jun 14;12:148. doi: 10.1186/1745-6215-12-148.

Supplemental Content

Loading ...
Support Center